Edwards Lifesciences Gross Margin Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 111.2  1.15  1.04%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Gross Margin of Edwards Lifesciences Corporation with missing and latest data points interpolated. Gross Margin measures the ratio between a company's Gross Profit and Revenues.
Gross Margin  10 Years Trend  
Increasing
Slightly volatile
 Gross Margin 
      Timeline 

Edwards Lifesciences Gross Margin Over Time

2015-12-31  0.75 
2016-12-31  0.73 
2017-12-31  0.78 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  0.7
Geometric Mean  0.7
Coefficient Of Variation  9.3
Mean Deviation  0.04564
Median  0.73
Standard Deviation  0.065499
Sample Variance  0.00429
Range  0.25
R Value  0.84
Mean Square Error  0.001398
R Squared  0.7
Significance  0.00064668
Slope  0.015241
Total Sum of Squares  0.047191

Currently Trending

TWTR   
 NYQ 
Purchased over 100 shares of
1 hour ago ago
Traded for 18.33
GOOG   
 NMS 
Purchased few shares of
1 hour ago ago
Traded for 992.0
F   
 NYQ 
Purchased over 200 shares of
1 hour ago ago
Traded for 12.19